Skip to main content

. 1961 Jan 28;1(5221):257. doi: 10.1136/bmj.1.5221.257

Agranulocytosis after Imipramine and Meprobamate

T P Curran, E Barabas

PMCID: PMC1953048 PMID: 20789052

257

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

BIRD C. E. Agranulocytosis due to imipramine (tofranil). Can Med Assoc J. 1960 May 14;82:1021–1022. [PMC free article] [PubMed] [Google Scholar]
CHARKES N. D. Meprobamate idiosyncrasy; report of a case and review of the literature. AMA Arch Intern Med. 1958 Oct;102(4):584–593. doi: 10.1001/archinte.1958.00260210070012. [DOI] [PubMed] [Google Scholar]
LEYBERG J. T., DENMARK J. C. The treatment of depressive states with imipramine hydrochloride (tofranil). J Ment Sci. 1959 Oct;105:1123–1126. doi: 10.1192/bjp.105.441.1123. [DOI] [PubMed] [Google Scholar]
MEYER L. M., HEEVE W. L., BERTSCHER R. W. Aplastic anemia after meprobamate (2-methyl-2-N-propyl-1,3-propanediol dicarbamate) therapy. N Engl J Med. 1957 Jun 27;256(26):1232–1233. doi: 10.1056/NEJM195706272562607. [DOI] [PubMed] [Google Scholar]

ACTIONS

RESOURCES